BGM
BGM Group Ltd. · NASDAQ
- Market cap
- $106.9M
BGM Group Ltd. (BGM) is a Biotechnology: Pharmaceutical Preparations company listed on NASDAQ. There were no new wire items for BGM in the last 30 days. The most recent was published Sep 24, 2026.
Financial highlights
Full financials- Revenue, FY2025
- $37.92M
- Revenue growth
- +51.1%
- Net income, FY2025
- -$19.94M
- Net margin
- -52.6%
- Free cash flow, FY2025
- -$3.94M
- Cash
- $9.82M
For fiscal 2025 (ended Sep 30, 2025), from SEC filings. Not investment advice.
News · 26 weeks100%
2026-05-242026-11-15
Mix390d
- SEC Filings3(100%)
Activity · 52 weeks2219 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news
Latest news
25 items- SECSEC Form 6-K filed by BGM Group Ltd.6-K - BGM Group Ltd. (0001779578) (Filer)
- SECSEC Form 6-K filed by BGM Group Ltd.6-K - BGM Group Ltd. (0001779578) (Filer)
- SECSEC Form 6-K filed by BGM Group Ltd.6-K - BGM Group Ltd. (0001779578) (Filer)
- SECSEC Form 6-K filed by BGM Group Ltd.6-K - BGM Group Ltd. (0001779578) (Filer)
- SECSEC Form 6-K filed by BGM Group Ltd.6-K - BGM Group Ltd. (0001779578) (Filer)
- SECSEC Form 6-K filed by BGM Group Ltd.6-K - BGM Group Ltd. (0001779578) (Filer)
- SECSEC Form 20-F filed by BGM Group Ltd.20-F - BGM Group Ltd. (0001779578) (Filer)
- SECSEC Form 6-K filed by BGM Group Ltd.6-K - BGM Group Ltd. (0001779578) (Filer)
- SECSEC Form 6-K filed by BGM Group Ltd.6-K - BGM Group Ltd. (0001779578) (Filer)
- SECSEC Form 6-K filed by BGM Group Ltd.6-K - BGM Group Ltd. (0001779578) (Filer)
- SECSEC Form 6-K filed by BGM Group Ltd.6-K - BGM Group Ltd. (0001779578) (Filer)
- INSIDERSEC Form 3 filed by new insider Ren Yuehua3 - BGM Group Ltd. (0001779578) (Issuer)
- INSIDERSEC Form 3 filed by new insider Zhai Yaxuan3 - BGM Group Ltd. (0001779578) (Issuer)
- INSIDERSEC Form 3 filed by new insider Xu Waihua3 - BGM Group Ltd. (0001779578) (Issuer)
- INSIDERSEC Form 3 filed by new insider Lou Zefei3 - BGM Group Ltd. (0001779578) (Issuer)
- SECSEC Form 6-K filed by BGM Group Ltd.6-K - BGM Group Ltd. (0001779578) (Filer)
- SECSEC Form 6-K filed by BGM Group Ltd.6-K - BGM Group Ltd. (0001779578) (Filer)
- INSIDERSEC Form 3 filed by new insider Zhang Lin (Henry)3 - BGM Group Ltd. (0001779578) (Issuer)
- PRBGM Group Ltd. Receives NASDAQ Notice Related to Late Filing of Form 20-FCHENGDU, China, Feb. 26, 2026 (GLOBE NEWSWIRE) -- BGM Group Ltd. (NASDAQ:BGM) (the "Company" or "BGM") announced on February 24, 2026, that it has received a notification (the "Notification") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") regarding its non-compliance with the Nasdaq Listing Rule 5250 (c)(1) as a result of the Company's failure to file its Annual Report on Form 20-F for the fiscal year ended September 30, 2025 (the "Form 20-F") in a timely manner. Pursuant to the Notification, the Company has 60 calendar days to submit to Nasdaq a plan to regain compliance from the date of receipt of the Notification and if the plan is accepted by Nas
- SECSEC Form NT 20-F filed by BGM Group Ltd.NT 20-F - BGM Group Ltd. (0001779578) (Filer)
- SECSEC Form 6-K filed by BGM Group Ltd.6-K - BGM Group Ltd. (0001779578) (Filer)
- SECSEC Form 6-K filed by BGM Group Ltd.6-K - BGM Group Ltd. (0001779578) (Filer)
- SECSEC Form 6-K filed by BGM Group Ltd.6-K - BGM Group Ltd. (0001779578) (Filer)
- PRBGM To Report First Half 2025 Unaudited Financial Results on July 24, 2025CHENGDU, China, July 23, 2025 /PRNewswire/ -- BGM Group (the "Company" or "BGM") (NASDAQ:BGM) today announced that it will release its unaudited financial results for the first half 2025 before the U.S. financial markets open on July 24, 2025 Eastern Daylight Time. About BGM BGM Group Ltd. has a strategic focus on the technology fields of AI application, intelligent robots, algorithmic computing power, cloud computing, and biopharmaceuticals. In terms of AI application implementation, the group relies on advanced analytics and AI Agent technology, and utilizes the two platforms of Du Xiao Bao and Bao Wang to provide comprehensive and professional AI solutions and intelligent robot services
- SECSEC Form 6-K filed by BGM Group Ltd.6-K - BGM Group Ltd. (0001779578) (Filer)
BGM FAQ
9 questionsWhat is the latest news on BGM?
Quantisnow has not tracked any new filings, ratings or press releases for BGM in the last 30 days. The most recent wire item was published on September 24, 2026.What is BGM revenue?
BGM Group Ltd. (BGM) reported $37.92M of revenue for fiscal 2025 (ended Sep 30, 2025). That is up 51.1% from the year before.Is BGM profitable?
No. BGM Group Ltd. reported a net loss of $19.94M for fiscal 2025 (ended Sep 30, 2025).How much cash and debt does BGM have?
BGM Group Ltd. reported $9.82M in cash and cash equivalents on its most recent balance sheet in SEC filings.Where does BGM stock trade?
BGM Group Ltd. (BGM) is listed on NASDAQ.What sector and industry is BGM in?
BGM Group Ltd. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did BGM Group Ltd. go public?
BGM Group Ltd. (BGM) completed its IPO in 2021.What companies are similar to BGM?
Notable peers in the same industry include ABT (Abbott Laboratories), JNJ (Johnson & Johnson), MRK (Merck & Company Inc.), NVO (Novo Nordisk A/S), AZN (AstraZeneca PLC). Compare BGM side-by-side with any of them on Quantisnow.How can I track BGM on Quantisnow?
Quantisnow aggregates BGM Group Ltd.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BGM to receive live email and push alerts on every new disclosure.